|
| 首药控股-U(688197)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-03-24 | 850.84 | 5.72% | 6427.46 | 8444.47 | 5476.45 | 36.82% | 首发原股东限售股份 | | 2024-03-25 | 148.72 | 1.00% | 5576.62 | 9295.31 | 5476.45 | 36.82% | 首发战略配售股份 | | 2023-09-27 | 143.14 | 0.96% | 5476.45 | 9395.48 | 3617.83 | 24.33% | 首发原股东限售股份 | | 2023-08-24 | 110.11 | 0.74% | 5333.31 | 9538.62 | 3617.83 | 24.33% | 首发原股东限售股份 | | 2023-07-24 | 110.11 | 0.74% | 5223.21 | 9648.73 | 3617.83 | 24.33% | 首发原股东限售股份 | | 2023-03-23 | 1495.27 | 10.05% | 5113.10 | 9758.84 | 3617.83 | 24.33% | 首发原股东限售股份 | | 2022-09-23 | 187.90 | 1.26% | 3617.83 | 11254.10 | 3617.83 | 24.33% | 首发机构配售股份 | | 2022-03-23 | 3381.38 | 22.74% | 3381.38 | 11490.56 | 3381.38 | 22.74% | 首发一般股份 |
|